Companies & Industry »Company News»Company News Details
Company News Details

BSE   21 Mar 18 | 12:00 AM

379.80 -5 (-1.3%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   21 Mar 18 | 12:00 AM

379.75 -5.7 (-1.48%)
Mkt Price (Rs)   Chg Rs (Chg %)
1 Week : Rs 385.25 (-1.41%)
1 Month : Rs 400.60 (-5.19%)
1 Year : Rs 441.80 (-14.03%)
change companytradenow

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

Widgets Magazine

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Widgets Magazine


Company Price Gain (%)
Bharti Airtel418.604.61
Larsen & Toubro1,308.401.14
H D F C1,818.851.05
HDFC Bank1,857.651.00

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine